Cargando…
Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation
Imbalances in endoplasmic reticulum (ER) proteostasis are associated with etiologically-diverse degenerative diseases linked to excessive extracellular protein misfolding and aggregation. Reprogramming of the ER proteostasis environment through genetic activation of the Unfolded Protein Response (UP...
Autores principales: | Plate, Lars, Cooley, Christina B, Chen, John J, Paxman, Ryan J, Gallagher, Ciara M, Madoux, Franck, Genereux, Joseph C, Dobbs, Wesley, Garza, Dan, Spicer, Timothy P, Scampavia, Louis, Brown, Steven J, Rosen, Hugh, Powers, Evan T, Walter, Peter, Hodder, Peter, Wiseman, R Luke, Kelly, Jeffery W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954754/ https://www.ncbi.nlm.nih.gov/pubmed/27435961 http://dx.doi.org/10.7554/eLife.15550 |
Ejemplares similares
-
Pharmacologic IRE1/XBP1s Activation Confers Targeted ER Proteostasis Reprogramming
por: Grandjean, Julia M.D., et al.
Publicado: (2020) -
Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis
por: Blackwood, Erik A., et al.
Publicado: (2019) -
Pharmacologic ATF6 activating compounds are metabolically activated to selectively modify endoplasmic reticulum proteins
por: Paxman, Ryan, et al.
Publicado: (2018) -
Small Molecule Proteostasis Regulators for Protein Conformational Diseases
por: Calamini, Barbara, et al.
Publicado: (2011) -
Divergent Proteome Reactivity Influences Arm-Selective Activation of Pharmacological Endoplasmic Reticulum Proteostasis Regulators
por: Kline, Gabriel M., et al.
Publicado: (2023)